S&D (A260970) Stock Overview
Develops and sells health functional food in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
A260970 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
S&D Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩72,700.00 |
| 52 Week High | ₩149,800.00 |
| 52 Week Low | ₩40,150.00 |
| Beta | 0.90 |
| 1 Month Change | 2.54% |
| 3 Month Change | -34.33% |
| 1 Year Change | 48.98% |
| 3 Year Change | 360.13% |
| 5 Year Change | 111.15% |
| Change since IPO | 1,520.96% |
Recent News & Updates
S&D's (KOSDAQ:260970) Solid Earnings May Rest On Weak Foundations
Nov 27
Should You Be Adding S&D (KOSDAQ:260970) To Your Watchlist Today?
Oct 15S&D Co., Ltd's (KOSDAQ:260970) 28% Cheaper Price Remains In Tune With Earnings
Oct 15S&D Co., Ltd's (KOSDAQ:260970) 29% Jump Shows Its Popularity With Investors
Aug 28When Should You Buy S&D Co., Ltd (KOSDAQ:260970)?
Aug 11Recent updates
S&D's (KOSDAQ:260970) Solid Earnings May Rest On Weak Foundations
Nov 27Should You Be Adding S&D (KOSDAQ:260970) To Your Watchlist Today?
Oct 15S&D Co., Ltd's (KOSDAQ:260970) 28% Cheaper Price Remains In Tune With Earnings
Oct 15S&D Co., Ltd's (KOSDAQ:260970) 29% Jump Shows Its Popularity With Investors
Aug 28When Should You Buy S&D Co., Ltd (KOSDAQ:260970)?
Aug 11Should You Be Adding S&D (KOSDAQ:260970) To Your Watchlist Today?
Jul 16Is S&D Co., Ltd (KOSDAQ:260970) Trading At A 30% Discount?
Jul 02S&D Co., Ltd's (KOSDAQ:260970) P/E Is Still On The Mark Following 53% Share Price Bounce
Jun 16After Leaping 28% S&D Co., Ltd (KOSDAQ:260970) Shares Are Not Flying Under The Radar
Apr 26Here's Why We Think S&D (KOSDAQ:260970) Is Well Worth Watching
Apr 11We Like S&D's (KOSDAQ:260970) Returns And Here's How They're Trending
Mar 04Investors Still Aren't Entirely Convinced By S&D Co., Ltd's (KOSDAQ:260970) Earnings Despite 31% Price Jump
Feb 06Investors Still Aren't Entirely Convinced By S&D Co., Ltd's (KOSDAQ:260970) Earnings Despite 37% Price Jump
Dec 11Returns On Capital Are A Standout For S&D (KOSDAQ:260970)
Nov 11At ₩34,850, Is It Time To Put S&D Co., Ltd (KOSDAQ:260970) On Your Watch List?
Oct 16Should You Be Adding S&D (KOSDAQ:260970) To Your Watchlist Today?
Jul 25There Are Reasons To Feel Uneasy About S&D's (KOSDAQ:260970) Returns On Capital
Jun 14Is Now An Opportune Moment To Examine S&D Co., Ltd (KOSDAQ:260970)?
Apr 23S&D Co., Ltd's (KOSDAQ:260970) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
Mar 18Investors Met With Slowing Returns on Capital At S&D (KOSDAQ:260970)
Mar 07Shareholder Returns
| A260970 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | 5.7% | -4.3% | -3.4% |
| 1Y | 49.0% | 29.2% | 63.5% |
Return vs Industry: A260970 exceeded the KR Chemicals industry which returned 29.2% over the past year.
Return vs Market: A260970 underperformed the KR Market which returned 63.5% over the past year.
Price Volatility
| A260970 volatility | |
|---|---|
| A260970 Average Weekly Movement | 10.8% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A260970's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A260970's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Kyung-Mok Yeo | www.isnd.co.kr |
S&D Co., Ltd develops and sells health functional food in South Korea. The company offers general functional food ingredients, health-oriented functional ingredients, and biological industry materials for the sleeping problems and glycoconjugate gastric functions. It provides health-oriented functional ingredients, such as Lindera glauca extract, Rice bran Extract, MPG-6/MPGT, RCS, and Xanthorrhizol, as well as other materials, including Pagopyridol, SD 1002F, and Panduratin.
S&D Co., Ltd Fundamentals Summary
| A260970 fundamental statistics | |
|---|---|
| Market cap | ₩210.30b |
| Earnings (TTM) | ₩20.10b |
| Revenue (TTM) | ₩147.51b |
Is A260970 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A260970 income statement (TTM) | |
|---|---|
| Revenue | ₩147.51b |
| Cost of Revenue | ₩114.57b |
| Gross Profit | ₩32.94b |
| Other Expenses | ₩12.85b |
| Earnings | ₩20.10b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.95k |
| Gross Margin | 22.33% |
| Net Profit Margin | 13.62% |
| Debt/Equity Ratio | 0% |
How did A260970 perform over the long term?
See historical performance and comparisonDividends
Does A260970 pay a reliable dividends?
See A260970 dividend history and benchmarks| S&D dividend dates | |
|---|---|
| Ex Dividend Date | Dec 29 2025 |
| Dividend Pay Date | Apr 20 2026 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 118 days |
Does A260970 pay a reliable dividends?
See A260970 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/22 23:33 |
| End of Day Share Price | 2025/12/22 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
S&D Co., Ltd is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Hyun Jeong Son | Yuanta Securities Korea Co., Ltd. |